Cushing’s syndrome Market

""Cushing’s syndrome Market is expected to grow with the CAGR of 8.91% over the forecast period.""

Rising prevalence of chronic diseases due to unhealthy & sedative lifestyle with surge in steroid abuse as well as increased geriatric population are major factors driving the growth of Global Cushing’s Syndrome Market.

Scope of the Cushing’s Syndrome Market Report:

Cushing’s syndrome is excess cortisol or stress hormone secretion in blood vessels and is caused by improper functioning of pituitary glands which are responsible for secreting adrenocorticotropic hormone (ACTH). The major symptoms of the Cushing’s syndrome include weight gain, fat tissue deposits around midsection & back, thinning and easily bruised skin and occasionally type2 diabetes and an appearance of pink or purple stretch marks whereas treatment consists of reducing the use of corticosteroids, by surgery, and medications. The collection of symptoms caused due to the high level of hormones called cortisol which is the produced in the adrenal glands having a variety of roles in body. It plays a vital role in maintaining blood pressure, reducing inflammation, and keeping heart and blood vessels functioning normally, and regulates to metabolize proteins, carbohydrates & fats in diet into usable energy. Cushing syndrome can cause due to various factors including from injectable corticosteroids like repeated injections for joint pain, bursitis and back pain, inhaled excessive dosage of steroid medicines for asthma as well as steroid skin creams for skin disorders such as eczema.

The global Cushing’s syndrome market is segmented into disease type, treatment, end-users, region and country level. On the basis of disease type, the Cushing’s syndrome market can be segmented into exogenous Cushing’s syndrome and endogenous Cushing’s syndrome. On the basis of treatment, the global Cushing’s syndrome market is divided into surgery, radiation therapy, chemotherapy, drugs and others. The drugs segment is further divided into drug types such as mifepristone, Ketoconazole, Etomidate, Pasireotide, Aminoglutethimide and others. The drug segment has reported substantial growth for this market due to factors such as their noninvasive nature, fewer side effects than radiation therapies and effectiveness of drugs. The global Cushing’s syndrome market, on the basis of end-users is segmented into hospitals & clinics, home care settings and others.

The regions covered in global Cushing’s syndrome market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, global Cushing’s syndrome market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Cushing’s Syndrome Manufacturers:

Global Cushing’s syndrome market reports cover prominent players like,

• IPSEN Biopharma Limited
• HRA Pharma
• Novartis
• Bristol-Myers Squibb
• Pfizer
• Concept Therapeutics
• HRA Pharma
• Others.

Global Cushing’s Syndrome Market Dynamics–

The key factor for growth of global Cushing’s syndrome market is rising prevalence of chronic diseases due to unhealthy lifestyle with surge in steroid abuse dosage as well as increased geriatric population are important factor. According to a recent study by European Registry on CS (ERCUSYN) in 2019; Patients with Cushing’s syndrome (CS) have increased mortality rate due to progression of infectious diseases by 31%, cardiovascular disease  with 17% , 67%  had pituitary-dependent CS, 25% adrenal-dependent CS and remaining 5% had an ectopic source. Thus aim of this study was to evaluate the causes and time of death in a large amount of patients with CS and to establish factors associated with increased mortality. According to Orphanet Journal of Rare Diseases, the incidence of Cushing’s syndrome is estimated to be equal to 1–3 cases per million people annually, whereas its prevalence rate is 40 cases per million people. A disease of the pituitary gland has been characterized by the excess amount of adrenocorticotropic hormone (ACTH) hyper secretion of cortisol by the adrenal glands which lead to Cushing’s syndrome.

However, its treatment may cause complications, including liver toxicity, adrenal gland issues, and heart problems, lack of awareness about the latest treatment options, and high cost of drugs may hamper the market growth. In spite of that, rising technological advancements in the treatment of Cushing’s syndrome, early identification and monitoring of this Cushing’s disease and its associated complications, and surge in the number of innovative and effective treatments can provide huge opportunities for the further growth of the global Cushing’s syndrome market.  

Global Cushing’s Syndrome Market Regional Analysis–

North America is expected to dominate the Cushing’s syndrome market with the potential rate as increased prevalence of cardiovascular disease (CVD) due to rising levels of obesity, and rising physical inactivity in this region. According to American Heart Association, Cardiovascular disease (CVD) is considered as the major cause of death, counted for 840,678 deaths in the U.S. in 2016 which accounts for the development of Cushing’s syndrome by 17%. According to American Association of Neurological Surgeons, in North America annually more than 10-15 per million people are affected due to Cushing’s disease out of which more than 70 percent of cases in adults and about 60-70 percent of cases in children and adolescents. The disease is more prevalent in females, accounting for about 70 percent of all cases.

Europe is the second-largest region in global Cushing’s syndrome market due to prevalence of chronic diseases and infectious diseases with increased mortality rate due to Cushing syndromes in this region. The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases i.e., diabetes, heart failure etc. with rising population in this region.

Key Benefits for Global Cushing’s Syndrome Market Report–

Global Cushing’s syndrome market report covers in depth historical and forecast analysis.

Global Cushing’s syndrome market research report provides detail information about market introduction, market summary, global market revenue (revenue USD), market drivers, market restraints, market opportunities, competitive analysis, regional and country level.

Global Cushing’s syndrome market report helps to identify opportunities in market place.

Global Cushing’s syndrome market report covers extensive analysis of emerging trends and competitive landscape.

Global Cushing’s Syndrome Market Segmentation:–

By Disease Type: 

• Exogenous Cushing’s syndrome
• Endogenous Cushing’s syndrome

By Treatment Type: 

• Surgery
• adiation therapy
• Chemotherapy
• Drugs
• Mifepristone
• Ketoconazole
• Etomidate
• Pasireotide
• Aminoglutethimide
• Others

By End-user Type: 

• Hospitals
• clinics
• Home care settings
• Others

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa